Skip to main content
. 2013 Jan;87(2):1274–1277. doi: 10.1128/JVI.01777-12

Fig 2.

Fig 2

In vivo replication of HIVJR-CSF and HIVJR-CSF K65R after i.p. injection into humanized mice shows no overt difference in replication capacity. Humanized NOD/SCID/γ−/− mice (28, 29) were infected with equal amounts of either HIV-1JR-CSF or HIV-1JR-CSF K65R (3 × 104 TCIU) by i.p. injection. The course of infection was monitored by determining plasma viral loads. Dotted line indicates the limit of detection of the assay.